240 related articles for article (PubMed ID: 3472637)
1. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma.
Buccheri GF; Violante B; Sartoris AM; Ferrigno D; Curcio A; Vola F
Cancer; 1986 Jun; 57(12):2389-96. PubMed ID: 3697937
[TBL] [Abstract][Full Text] [Related]
3. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
4. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
6. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
[TBL] [Abstract][Full Text] [Related]
7. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
[TBL] [Abstract][Full Text] [Related]
8. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of five tumor marker assay in patients with lung cancer.
Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
11. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay.
Mizushima Y; Hirata H; Izumi S; Hoshino K; Konishi K; Morikage T; Maruyama M; Yamashita N; Yano S
Oncology; 1990; 47(1):43-8. PubMed ID: 2300384
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer.
Buccheri G; Ferrigno D
Chest; 1988 Mar; 93(3):565-70. PubMed ID: 3342667
[TBL] [Abstract][Full Text] [Related]
16. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.
Falcone F; Sabbatani S; Fini A; Turba E; Magri P; D'Ales A
Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127
[TBL] [Abstract][Full Text] [Related]
17. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
Putzki H; Student A; Jablonski M; Heymann H
Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817
[TBL] [Abstract][Full Text] [Related]
19. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
